| James Edward Armstrong, | |
|
800 Hospital Dr, Madisonville, KY 42431-1658 | |
| (270) 326-4800 | |
| Not Available |
| Full Name | James Edward Armstrong |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 15 Years |
| Location | 800 Hospital Dr, Madisonville, Kentucky |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922240308 | NPI | - | NPPES |
| 7100130830 | Medicaid | KY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 01086337A (Indiana) | Secondary |
| 208600000X | Surgery | 47368 (Kentucky) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Baptist Health Floyd | New albany, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Baptist Health Medical Group Inc | 5597867184 | 1912 |
News Archive
Transave Inc. today announced that the United States Patent and Trademark Office has issued an important composition of matter patent (U.S. Patent No. 7,718,189) for liposomal aminoglycoside formulations including its lead compound, ARIKACE™ (liposomal amikacin for inhalation). The company expects that the patent will provide exclusivity for ARIKACE until October 1, 2026.
To parents, learning that a child has been diagnosed with autism can be overwhelming. Children with the disorder can seem trapped in a world of their own, without friends or even a conception of friendship. Many prefer to play alone. Some lose the ability to speak more than a few words.
Amira Pharmaceuticals, Inc. announced today that it has achieved another development milestone in its FLAP program, which is partnered with GlaxoSmithKline. This milestone is related to the successful development of a solid dose formulation, which is critical for future development and commercialization activities.
A war is being waged in the pancreases of millions of people throughout the world. The siege leads to the development of type 1 diabetes and has been a battlefield largely hidden from view- until now.
› Verified 3 days ago
| Entity Name | Baptist Health Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508269200 PECOS PAC ID: 5597867184 Enrollment ID: O20090527000129 |
News Archive
Transave Inc. today announced that the United States Patent and Trademark Office has issued an important composition of matter patent (U.S. Patent No. 7,718,189) for liposomal aminoglycoside formulations including its lead compound, ARIKACE™ (liposomal amikacin for inhalation). The company expects that the patent will provide exclusivity for ARIKACE until October 1, 2026.
To parents, learning that a child has been diagnosed with autism can be overwhelming. Children with the disorder can seem trapped in a world of their own, without friends or even a conception of friendship. Many prefer to play alone. Some lose the ability to speak more than a few words.
Amira Pharmaceuticals, Inc. announced today that it has achieved another development milestone in its FLAP program, which is partnered with GlaxoSmithKline. This milestone is related to the successful development of a solid dose formulation, which is critical for future development and commercialization activities.
A war is being waged in the pancreases of millions of people throughout the world. The siege leads to the development of type 1 diabetes and has been a battlefield largely hidden from view- until now.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| James Edward Armstrong, 2125 State St, Ste 3, New Albany, IN 47150-4972 Ph: (812) 944-2663 | James Edward Armstrong, 800 Hospital Dr, Madisonville, KY 42431-1658 Ph: (270) 326-4800 |
News Archive
Transave Inc. today announced that the United States Patent and Trademark Office has issued an important composition of matter patent (U.S. Patent No. 7,718,189) for liposomal aminoglycoside formulations including its lead compound, ARIKACE™ (liposomal amikacin for inhalation). The company expects that the patent will provide exclusivity for ARIKACE until October 1, 2026.
To parents, learning that a child has been diagnosed with autism can be overwhelming. Children with the disorder can seem trapped in a world of their own, without friends or even a conception of friendship. Many prefer to play alone. Some lose the ability to speak more than a few words.
Amira Pharmaceuticals, Inc. announced today that it has achieved another development milestone in its FLAP program, which is partnered with GlaxoSmithKline. This milestone is related to the successful development of a solid dose formulation, which is critical for future development and commercialization activities.
A war is being waged in the pancreases of millions of people throughout the world. The siege leads to the development of type 1 diabetes and has been a battlefield largely hidden from view- until now.
› Verified 3 days ago
Jack L Hamman, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 800 Hospital Dr, Madisonville, KY 42431 Phone: 270-326-3800 Fax: 270-326-3805 | |
Mohan K. Rao, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 800 Hospital Dr, Madisonville, KY 42431 Phone: 270-326-4800 Fax: 270-326-4820 | |
Dr. Joshua Clapp, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 800 Hospital Dr Fl 3, Madisonville, KY 42431 Phone: 270-326-4780 Fax: 270-326-4804 | |
Henry Garth Smith, DMD MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1900 N Main St, Madisonville, KY 42431 Phone: 270-245-2105 Fax: 270-452-2355 | |
Darren Craig Chapman, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 800 Hospital Dr, Madisonville, KY 42431 Phone: 270-326-4800 Fax: 270-326-4820 |